Company intelligence / Profile preview

ASLAN Pharmaceuticals

Singapore, Central, Singapore

Ownership: Public · ASLN
Employees: ~38
Development stage: Phase 2

Overview

ASLAN Pharmaceuticals was a clinical-stage immunology-focused biopharmaceutical company. Its lead asset eblasakimab showed positive topline data in a Phase 2b study for moderate-to-severe atopic dermatitis in biologic-naïve patients. Farudodstat was being evaluated as an oral treatment for alopecia areata with interim readout expected mid-2024. The company previously completed a Phase II/III trial of varlitinib in gastric cancer but has since focused on immunology and dermatology indications. In July 2024, the company announced voluntary liquidation of its sole operating subsidiary due to financial difficulties[1][7][10].

Therapeutic areas: OncologyImmunologyDermatology
Modalities: Monoclonal antibodies (mAbs)Small molecules
Industry: Biotech

Drug pipeline

4 assets

varlitinib

3 more assets in the full pipeline.

Request access →

Partnerships

Zenyaku Kogyo Co., Ltd.: research collaboration for development/commercialization of eblasakimab in Japan[4].Thermo Fisher Scientific Inc.: manufacturing partnership for high concentration formulation of eblasakimab for late-stage trials[6].

Financials

Market cap: $777.1M
Total revenue: $0
Enterprise value: $785.4M

Beyond the preview

Go deeper on ASLAN Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASLAN Pharmaceuticals.

Explore the full profile